$EMN

Eastman Chemical: Q3 Earnings Snapshot

Eastman Chemical (EMN) reported Q3 net income of $252M ($2.19 per share), missing analyst estimates of $1.92 per share. Adjusted EPS was $1.84. Revenue was $2.38B, below expectations of $2.39B, according to Zacks.

Original reporting
Published Oct 29, 2026, 8:55 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 9:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Eastman Chemical: Q3 Earnings Snapshot — source image
Decision brief

The 30-second read

$EMNBearishMed
01

Why it matters

Eastman’s Q3 EPS and revenue both came in below analyst expectations, creating a near-term earnings disappointment signal for traders.

02

Market read

Traders can use the reported EPS and revenue shortfalls versus consensus to reassess near-term earnings expectations for EMN.

03

What to watch

The article does not include guidance, segment performance, or cash flow, which are often the key drivers of post-earnings moves beyond the headline EPS and revenue comparisons.

Relevance 7/10Novelty 6/10Timing: reported Thursday Q3 results

Background

The piece is an AP-generated earnings snapshot using Zacks consensus figures for comparison.

Company-level read

Ticker impact

$EMNBearishHigh confidence
Context

Eastman Chemical reported Q3 net income of $252 million and adjusted EPS of $1.84, missing Zacks’ $1.92 estimate.

Expected impact

Likely downside bias as the market digests the EPS and revenue shortfalls versus expectations.

Evidence & confidence

The article provides the company’s reported EPS and revenue and states both missed Wall Street expectations, which is a direct earnings-surprise catalyst.

Market effects

A miss at a specialty chemicals name can reinforce cautious sentiment around pricing power and margins in the sector.

Limited, mostly affects US specialty chemicals sentiment rather than broad regional fundamentals.

Low, as the disclosure is company-specific and not tied to global macro or supply shocks.

Counterpoint

If the miss is driven by non-recurring items or temporary demand softness, the stock could stabilize on any underlying margin resilience not captured in this brief.

Key entities

  • Eastman Chemical Co.

    Specialty chemicals maker reporting Q3 net income and adjusted EPS versus Zacks estimates.

  • Zacks Investment Research

    Provides the consensus EPS and revenue expectations cited in the article.

Related articles

$EMNHighAI 8/10

Eastman Announces Third-Quarter 2026 Financial Results

EASTMAN CHEMICAL CO (EMN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.01 Eastman Announces Third-Quarter 2026 Financial Results KINGSPORT, Tenn., October 29, 2026 – Eastman Chemical Company (NYSE:EMN) announced its third-quarter 2026 financial results. • Delivered EPS growth and solid cash flow in a dynamic environment • Strong performan

$EMNHigh

Eastman Chemical (EMN) Shares Drop 2.6% After J.P. Morgan Downgr

Eastman Chemical (EMN) shares fell 2.6% after J.P. Morgan downgraded it to Neutral with a $66 price target, citing unfavorable commodity spreads. The company offers a 5.58% dividend yield but has a high payout ratio of 75%. EMN's GF Score is 76, indicating solid fundamentals with some concerns. Insiders have sold shares, while some institutional investors have added to positions.

$EMNMed

Moody’s shifts Eastman Chemical outlook on cash flow concerns

Moody’s Ratings changed Eastman Chemical’s outlook to negative from stable, while keeping its Baa2 issuer and senior unsecured ratings and Prime-2 commercial paper rating. The move cites weaker-than-expected operating cash flow for 2026, lower expected cash flow near $900 million, and higher debt leverage versus the downgrade trigger. Eastman expects 2026 EBITDA about $1.5 billion.